Percutaneous Cryoablation Peripheral Lung Cancer
Not Applicable
- Conditions
- Lung Cancer
- Registration Number
- NCT02665390
- Lead Sponsor
- Shanghai Chest Hospital
- Brief Summary
This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.
- Detailed Description
The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
medically inoperable peripheral lung cancer Diameter no more than 3cm
Exclusion Criteria
- Refusal of participation
- tendency to bleed to that can't receive percutaneous cryoablation.
- Severe cardiopulmonary dysfunction and other indications that can't receive percutaneous cryoablation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method PFS 2 years
- Secondary Outcome Measures
Name Time Method OS 2 years